In conclusion, our research findings indicate that SMS alleviates lipid accumulation, oxidative stress, and inflammation in NAFLD by inhibiting the ROS/TXNIP/NLRP3-mediated pyroptosis pathway (Figure 11). Here, TXNIP is linked to metabolic dysfunction-associated steatotic liver disease.